Observation on the effect of hydrogel probiotics colonized in inflammatory sites in the treatment of inflammatory bowel disease

doi:10.3969/j.issn.1674-8115.2024.07.009

Abstract

Abstract:

Objective ·To construct a probiotic ( Escherichia coli Nissle1917,EcN) system (EcN@PVA-ALG) loaded on polyvinyl alcohol (PVA) / alginate (ALG) hydrogel (PVA-ALG) rich in negative hydroxyl groups, and to explore its colonization in the inflammatory site of colon and its therapeutic effect on dextran sulfate sodium salt (DSS)-induced inflammatory bowel disease (IBD). Methods ·EcN suspension was added to the PVA-ALG hydrogel, and then EcN@PVA-ALG hydrogel probiotic complex was obtained after screening and centrifugation. The synthesis of PVA-ALG hydrogel was verified by rheometer. The surface charge of EcN@PVA-ALG was detected by potentiometer and the load of EcN on PVA-ALG was observed by fluorescence microscope. The absorbance of EcN@PVA-ALG at 600 nm was detected by enzyme labeling instrument. Meanwhile, the bacterial plate count of EcN@PVA-ALG complex suspension was taken to study the growth activity of EcN in EcN@PVA-ALG. The CCK-8 kit was used to assess the inhibitory ability of EcN@PVA-ALG on HEK cell proliferation. In vivo imaging system (IVIS) was used to firstly analyze the enrichment of PVA-ALG on inflammatory colon to study its inflammatory targeting property; then EcN was loaded on PVA-ALG, and IVIS was used to observe the enrichment of EcN@PVA-ALG on inflammatory colon to study its ability to colonize the inflammatory site. To establish the model of IBD mice induced by DSS, EcN@PVA-ALG group ( n=5) was given 1×10 ⁸CFU EcN@PVA-ALG every day for 5 d, and PVA-ALG group, EcN group, PBS group and healthy control group with 5 mice were set up. During the treatment, the body mass of the mice was recorded every day. After treatment, the colonic tissue was taken, and the length of colon was measured. The disease activity index (DAI) score was graded. The levels of inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-10 and transforming growth factor-β (TGF-β) were detected, and the pathological evaluation of colonic tissue was made by H-E staining. Results ·Both PVA-ALG and EcN@PVA-ALG were negatively charged. EcN was successfully loaded onto PVA-ALG and PVA-ALG did not affect the growth viability of EcN, which contributed to the subsequent colonization of inflammatory colons. PVA-ALG had a favorable safety profile on normal cells. Compared with healthy controls, PVA-ALG had more than 2-fold enrichment effect on inflammatory colon tissue. In vitro and in vivo experiments revealed that EcN@PVA-ALG complex loaded with EcN had 8 times higher enrichment effect on inflammatory tissue than EcN without any modification. After EcN@PVA-ALG treatment, the body weight of mice recovered rapidly. The increase of DAI was significantly inhibited. The length of colon was similar to that of healthy mice. The levels of TNF- α and IL-6 decreased, while the levels of IL-10 and TGF- β increased. The crypt structure of colon tissue recovered. Conclusion ·Compared to unmodified EcN, EcN@PVA-ALG promotes the colonization of EcN at inflammatory sites of colon and allows it to exert better efficacy on treating DSS-induced IBD.

Key words: probiotics, hydrogel, inflammatory bowel disease, inflammatory colonization

CLC Number:

R574.4

XU Wei, LI Meng, WANG Haoze, CUI Kai, XIAO Zeyu. Observation on the effect of hydrogel probiotics colonized in inflammatory sites in the treatment of inflammatory bowel disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(7): 883-890.

Figures/Tables 6

Fig 1 Preparation and characterization of EcN@PVA-ALG

Fig 2 Bacterial viability and cytotoxicity of EcN@PVA-ALG

Fig 3 Targeting of PVA-ALG hydrogels in health and disease states

Fig 4 Inflammatory colonization of EcN and EcN@PVA-ALG

Fig 5 Effect of EcN@PVA-ALG on IBD

Fig 6 Pathological evaluation of colonic tissue (H-E staining)

TrendMD

References 23

1	DANNE C, SKERNISKYTE J, MARTEYN B, et al. Neutrophils: from IBD to the gut microbiota[J]. Nat Rev Gastroenterol Hepatol, 2024, 21: 184-197.
2	BISGAARD T H, ALLIN K H, KEEFER L, et al. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment[J]. Nat Rev Gastroenterol Hepatol, 2022, 19: 717-726.
3	SCOTT B M, GUTIÉRREZ-VÁZQUEZ C, SANMARCO L M, et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease[J]. Nat Med, 2021, 27: 1212-1222.
4	NEURATH M F. Current and emerging therapeutic targets for IBD[J]. Nat Rev Gastroenterol Hepatol, 2017, 14: 269-278.
5	LE BERRE C, HONAP S, PEYRIN-BIROULET L. Ulcerative colitis [J]. Lancet, 2023, 402(10401): 571-584.
6	KOBAYASHI T, HIBI T. Improving IBD outcomes in the era of many treatment options[J]. Nat Rev Gastroenterol Hepatol, 2023, 20: 79-80.
7	MAO R, CHEN M H. Precision medicine in IBD: genes, drugs, bugs and omics[J]. Nat Rev Gastroenterol Hepatol, 2022, 19: 81-82.
8	COLOMBEL J F, SANDBORN W J, REINISCH W, et al. Infliximab, azathioprine, or combination therapy for Crohn′s disease[J]. N Engl J Med, 2010, 362(15): 1383-1395.
9	CURVINO E J, ROE E F, FREIRE HADDAD H, et al. Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres[J]. Nat Biomed Eng, 2024, 8: 628-649.
10	HILL C, GUARNER F, REID G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J]. Nat Rev Gastroenterol Hepatol, 2014, 11: 506-514.
11	SALMINEN S, COLLADO M C, ENDO A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics[J]. Nat Rev Gastroenterol Hepatol, 2021, 18: 649-667.
12	BUTEL M J. Probiotics, gut microbiota and health[J]. Med Mal Infect, 2014, 44(1): 1-8.
13	LUO H, WU F, WANG X, et al. Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating[J]. Mater Today, 2023, 62: 98-110.
14	SONG W F, YAO W Q, CHEN Q W, et al. In situ bioorthogonal conjugation of delivered bacteria with gut inhabitants for enhancing probiotics colonization[J]. ACS Cent Sci, 2022, 8(9): 1306-1317.
15	KURTZ C B, MILLET Y A, PUURUNEN M K, et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans[J]. Sci Transl Med, 2019, 11(475): eaau7975.
16	WANG X, CAO Z, ZHANG M, et al. Bioinspired oral delivery of gut microbiota by self-coating with biofilms[J]. Sci Adv, 2020, 6(26): eabb1952.
17	CARONE M, SPALINGER M R, GAULTNEY R A, et al. Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitis[J]. Nat Commun, 2023, 14: 3489.
18	YASMIN F, NAJEEB H, SHAIKH S, et al. Novel drug delivery systems for inflammatory bowel disease[J]. World J Gastroenterol, 2022, 28(18): 1922-1933.
19	LIU H, CAI Z, WANG F, et al. Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora[J]. Adv Sci, 2021, 8(18): e2101619.
20	HUANG H B, GONG W, HOU Y Y, et al. Mucoadhesive hydrogel with anti-gastric acid and sustained-release functions for amelioration of DSS-induced ulcerative colitis[J]. J Agric Food Chem, 2023, 71(9): 4016-4028.
21	ZHANG K, ZHU L, ZHONG Y, et al. Prodrug integrated envelope on probiotics to enhance target therapy for ulcerative colitis[J]. Adv Sci (Weinh), 2023, 10(4): e2205422.
22	ZHANG S, ERMANN J, SUCCI M D, et al. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease[J]. Sci Transl Med, 2015, 7(300): 300ra128.
23	MING Z, HAN L, BAO M, et al. Living bacterial hydrogels for accelerated infected wound healing[J]. Adv Sci (Weinh), 2021, 8(24): e2102545.

[1]	XIA Xixi, DING Keke, ZHANG Huiheng, PENG Xufei, SUN Yimin, TANG Yajun, TANG Xiaofang. Research progress of the role of intestinal microbiota-mediated bile acids in inflammatory bowel disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(7): 839-846.
[2]	LU Yuhan, SHI Yahong, LONG Manmei, WANG Zi, WU Yingwei. Effect of ceria nanoparticles on activity of DSS-induced colitis in mice by eliminating active oxygen species [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(1): 35-42.
[3]	CHEN Zehao, LÜ Zhendong, ZHANG Zhen, CUI Wenguo, ZHANG Yuhui. Effect of hydrogel stiffness on nucleus pulposus cell phenotypes in vitro and its repairment of intervertebral disc in vivo [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(7): 804-813.
[4]	YANG Shu, CUI Wenguo, WEI Jie, CAI Zhengwei. Fabrication of self-healing injectable hyaluronic acid hydrogel for promoting angiogenesis [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1480-1492.
[5]	MA Fangfang, QIN Jiejie, REN Lingjie, TANG Xiaomei, LIU Jia, SHI Minmin, JIANG Lingxi. Establishment of a 3D culture model in vitro of pancreatic cancer primary cells using hydrogel microspheres [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 79-87.
[6]	DONG Jiaoyun, SONG Fei, LU Shuliang, LIU Yan, TIAN Ming. Effects of cryogen spray combined with polymeric hydrogel on acute burn wounds [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 562-569.
[7]	LI Bowen, LIU Ningning, WANG Hui. Advances in gut microbiota in the pathogenesis and treatment of inflammatory bowel disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 364-368.
[8]	JIANG Yi, JIANG Ping, ZHANG Mingming, FANG Jingyuan. Research progress in the role of Akkermansia muciniphila in gut-related diseases [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1490-1497.
[9]	Yi WU, Fang FANG, Hao HUANG, Ying CHEN. Influences of oral administration of probiotics on postoperative infection and liver function recovery in patients with partial hepatectomy [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(1): 9-15.
[10]	Tung-liang HSIA, Jia-chen DONG, Rong SHU. Application of hydrogel sustained-release system to periodontal tissue regeneration [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 959-962.
[11]	Yu-jie XIE, Li-juan XIE, Tian-wen ZHU, Yi-wen WANG. Study on interleukin-10 receptor A gene mutations-induced neonatal very early onset inflammatory bowel disease in 2 infants [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 409-412.
[12]	Chuan-dong CAI, Fei WANG, Wen-guo CUI, Cun-yi FAN, Shen LIU. Fabrication and characterization of matrix metalloproteinase-responsive G4 PAMAM-IBU/GelMA hydrogel [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 140-146.
[13]	LIU Li-li1, CUI Wen-guo1, 2. Injectable hydrogel loaded with bone morphogenetic protein-2 microspheres for bacteriostasis and osteogenesis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(9): 1184-1192.
[14]	LI Yue1, 2, SUN Han-xiao2, SHU Jie2, LI Yong-mei1#, SHENG Hui-ming2#. Anti-inflammatory effects of liraglutide on innate lymphoid cells in mice with inflammatory bowel disease [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(6): 744-751.
[15]	ZHOU Cheng, SUN Peng-fei, YIN Ji-yao, WANG Yang-yang, XIAO Hai-juan. Evolution of clinical treatment in inflammatory bowel diseasesfecal microbiota transplantation [J]. , 2020, 40(2): 267-.